Condition: Coronary Artery Disease (CAD) · Artificial Intelligence Algorithms · Face · Sponsor: China National Center for Cardiovascular Diseases
This study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are: 1. To verify if the AI algorithm can accurately distinguish between high-risk and low-risk groups by comparing the actual prevalence of CAD in these groups. 2. To compare the CAD detection rate using this AI screening strategy against the natural detection rate in a real-world cohort.
This description comes directly from the study's public registry record.
zhe zheng, MD, PhD · +86-010-88398027 · zhengzhe@fuwai.com
Always discuss trial participation with your own doctor first.
| Zhoukou Chuanhui District Hospital of Traditional Chinese Medicine | Zhoukou, Henan, China | Recruiting |
| Zhoukou Specialized Disease Hospital | Zhoukou, Henan, China | Recruiting |
| Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07277686